直接口服抗凝剂：一种治疗阿尔茨海默病的新疗法？ - Suppr

Suppr

超能文献

Direct oral anticoagulants: a new therapy against Alzheimer's disease?

作者信息

Grossmann Klaus

机构信息

Center for Plant Molecular Biology (ZMBP), University of Tübingen, Tübingen, Germany.

出版信息

Neural Regen Res. 2021 Aug;16(8):1556-1557. doi: 10.4103/1673-5374.303029.

DOI:10.4103/1673-5374.303029

PMID:33433480

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8323692/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/284e/8323692/20c60ddbb6cc/NRR-16-1556-g001.jpg

相似文献

Direct oral anticoagulants: a new therapy against Alzheimer's disease?直接口服抗凝剂：一种治疗阿尔茨海默病的新疗法？

Neural Regen Res. 2021 Aug;16(8):1556-1557. doi: 10.4103/1673-5374.303029.

Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer's Disease and the General Population in Australia.澳大利亚阿尔茨海默病患者和普通人群中口服抗凝剂使用的趋势和预测因素。

J Alzheimers Dis. 2019;70(3):733-745. doi: 10.3233/JAD-190094.

Clinical outcomes of direct oral anticoagulants after lower extremity arterial procedures.下肢动脉手术后直接口服抗凝剂的临床疗效。

Vascular. 2018 Apr;26(2):189-193. doi: 10.1177/1708538117724646. Epub 2017 Aug 18.

Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.评估直接口服抗凝剂治疗癌症相关性血栓：更新。

J Thromb Thrombolysis. 2019 Apr;47(3):409-419. doi: 10.1007/s11239-018-1783-2.

[Direct oral anticoagulants: In which indications? Which one to prescribe? For or against their use in frail patients and in atypical cases? Which monitoring and management haemorrhage complications?].[直接口服抗凝剂：适用于哪些适应症？开哪种药？支持还是反对在体弱患者和非典型病例中使用？如何监测和处理出血并发症？]

Rev Med Interne. 2020 Sep;41(9):598-606. doi: 10.1016/j.revmed.2020.05.026. Epub 2020 Jul 14.

Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants.患者对口服抗凝药物治疗的依从性：维生素 K 拮抗剂与直接口服抗凝剂的比较。

Int J Cardiol. 2021 Jun 15;333:162-166. doi: 10.1016/j.ijcard.2021.03.003. Epub 2021 Mar 8.

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响：SWAN 研究。

PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.

Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.直接口服抗凝剂用于血液系统恶性肿瘤患者预防静脉血栓栓塞和中风的安全性及有效性

J Oncol Pharm Pract. 2020 Mar;26(2):351-360. doi: 10.1177/1078155219848810. Epub 2019 May 29.

A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.一项单中心回顾性队列研究：比较低分子肝素与直接口服抗凝剂治疗癌症患者静脉血栓栓塞症——真实世界经验

J Oncol Pharm Pract. 2019 Jun;25(4):793-800. doi: 10.1177/1078155218757856. Epub 2018 Feb 20.

Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials.新型口服抗凝剂在预防心房颤动中风中的出血风险：随机对照试验的荟萃分析。

Cardiovasc Drugs Ther. 2013 Feb;27(1):23-35. doi: 10.1007/s10557-012-6426-9.

引用本文的文献

Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease.用于阿尔茨海默病中纤维蛋白概念验证PET成像的脑穿透肽和抗体放射性配体。

EJNMMI Radiopharm Chem. 2025 Sep 8;10(1):59. doi: 10.1186/s41181-025-00383-2.

Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases.纤维蛋白（原）的细胞机制：来自神经退行性疾病的见解

Front Neurosci. 2023 Jul 17;17:1197094. doi: 10.3389/fnins.2023.1197094. eCollection 2023.

Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems.阿尔茨海默病中的血管功能障碍：血浆接触和纤维蛋白溶解系统的改变。

Int J Mol Sci. 2023 Apr 11;24(8):7046. doi: 10.3390/ijms24087046.

Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021.直接口服抗凝剂与维生素 K 拮抗剂在 80 岁及以上人群中的应用：2021 年概述。

Int J Environ Res Public Health. 2023 Jan 13;20(2):1448. doi: 10.3390/ijerph20021448.

Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.直接口服抗凝剂（DOACs）用于靶向治疗凝血酶，凝血酶是阿尔茨海默病脑血管和神经元功能障碍的关键介质。

Biomedicines. 2022 Aug 4;10(8):1890. doi: 10.3390/biomedicines10081890.

In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (A) Complex at Different pH Conditions.在不同 pH 值条件下依诺肝素对载脂蛋白 E4-淀粉样蛋白-β（A）复合物的拮抗作用的计算机分析。

Biomolecules. 2022 Mar 25;12(4):499. doi: 10.3390/biom12040499.

Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.阿尔茨海默病：使用凝血酶抑制剂达比加群酯治疗的合理性。

Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.

本文引用的文献

Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.将阿尔茨海默病的遗传风险转化为机制见解和药物靶点。

Science. 2020 Oct 2;370(6512):61-66. doi: 10.1126/science.abb8575.

Anticoagulants for Treatment of Alzheimer's Disease.抗凝血剂治疗老年痴呆症。

J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease.先天免疫蛋白 IFITM3 调节阿尔茨海默病中的 γ-分泌酶。

Nature. 2020 Oct;586(7831):735-740. doi: 10.1038/s41586-020-2681-2. Epub 2020 Sep 2.

Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer's Disease.凝血酶，神经血管界面处凝血、炎症和神经毒性的介质：对阿尔茨海默病的影响。

Front Neurosci. 2020 Jul 24;14:762. doi: 10.3389/fnins.2020.00762. eCollection 2020.

Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.脑淀粉样血管病与阿尔茨海默病——一种肽，两种途径。

Nat Rev Neurol. 2020 Jan;16(1):30-42. doi: 10.1038/s41582-019-0281-2. Epub 2019 Dec 11.

Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.长期达比加群治疗可延缓 TgCRND8 小鼠模型阿尔茨海默病的发病机制。

J Am Coll Cardiol. 2019 Oct 15;74(15):1910-1923. doi: 10.1016/j.jacc.2019.07.081.

A vicious cycle of β amyloid-dependent neuronal hyperactivation.β 淀粉样蛋白依赖性神经元过度激活的恶性循环。

Science. 2019 Aug 9;365(6453):559-565. doi: 10.1126/science.aay0198.

Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes.淀粉样 β 寡聚体通过信号转导至周细胞来收缩阿尔茨海默病患者的人毛细血管。

Science. 2019 Jul 19;365(6450). doi: 10.1126/science.aav9518. Epub 2019 Jun 20.

Blood will out: vascular contributions to Alzheimer's disease.血债血偿：血管对阿尔茨海默病的贡献。

J Clin Invest. 2018 Feb 1;128(2):556-563. doi: 10.1172/JCI97509.

Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease.小胶质细胞衍生的 ASC 斑点在阿尔茨海默病中交叉引发淀粉样-β。

Nature. 2017 Dec 20;552(7685):355-361. doi: 10.1038/nature25158.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验